Featuring articles on semaglutide for prevention of cardiovascular events, an mRNA-based RSV PreF vaccine in older adults, recombinant or standard-dose influenza vaccine, tebentafusp in metastatic uveal melanoma, and on the predominance of Medicare Advantage; a review article on cannabis-related disorders and toxic effects; a case report of a woman with abnormal movements and confusion; and Perspective articles on medicine’s lessons for AI regulation, on “unwinding” continuous Medicaid coverage, and on something for sleep.

NEJM This Week — December 14, 2023

Get Started

Download the App